RadarScreener › OSTX

OSTX

OS Therapies Inc
NYSE · Pharmaceutical Preparations · EDGAR filings (CIK 1795091) · 19 signals · 2 setups · updated Aug 16, 2026

What the filings say Pressure ▼

The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K.

Radar 91 (high attention) · dilution pressure high · listing risk elevated · governance risk elevated · runway 0.1 mo · strongest signal: Runway < 6 months (Jun 30, 2026)

What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).

Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.

91Radar · attention score (0–100)
92Dilution pressure · financing + balance sheet
49Listing risk · exchange standards
50Governance risk · reporting, auditor, going concern

Setups

Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.

Forced-raise setup Pressure ▼ strength 0.95

The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (going-concern language, negative equity, runway < 6 months) coexists with live selling machinery (atm program, convertible note, equity line, pipe, registered direct, offering (424b)). Base case is a discounted raise; the question is when, not if.

Would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
Would invalidate: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).
ATM programConvertible noteEquity lineGoing-concern languageNegative equityPIPERegistered directRunway < 6 monthsOffering (424B)

Death-spiral watch Pressure ▼ strength 0.80

Variable-priced paper is outstanding while the listing is under stress — the structure where dilution can accelerate. Watch the share count each quarter. Discount-priced or variable-priced securities are outstanding while the company is managing its listing with reverse splits/notices. Each conversion lowers the price, which lowers the next conversion price.

Would confirm: Rising share count in 10-Q cover vs prior quarter; repeated 424B3 resales; another reverse split proposal.
Would invalidate: Notes repaid in cash / equity line terminated (8-K 1.02); share count flat quarter over quarter.
Convertible noteEquity lineReverse split

Analyst note

No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.

Pro on OSTX
Alerts
One email the morning OSTX files anything that matches your rules (types, minimum score, setups).
12-month history
Every signal and setup for OSTX back a year, not just 30 days — see how the current setup built.
Full analyst notes
What we noticed, evidence with links, what could prove us wrong, red-team caveats.
Full screener + CSV
All 985 flagged companies, same-day, sortable and exportable.
Get Pro · $18.85/mo founding rate   See a full Pro morning 35% off forever until Sept 30 · cancel any time

Balance sheet (XBRL)

$205Kcash + short-term investments as of Jun 30, 2026
0.1 moestimated runway (annualized 180-day YTD operating cash flow [companyfacts])
$-11.9Mstockholders' equity as of Jun 30, 2026
$49.6Mpublic float (10-K cover)
46.1Mshares outstanding as of Aug 12, 2026 · was 44.5M May 14, 2026

Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 47 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.

Signal timeline

Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.

DateSignalEvidenceScore
Aug 14, 2026 Going-concern language “going concern periodic” language in 10-Q (10-Q) filed 2026-08-14 filing 33
Aug 12, 2026 Equity line “equity line” language in 8-K (EX-4.1) filed 2026-08-12 filing 45
Aug 12, 2026 ATM program “atm” language in 8-K (EX-10.1) filed 2026-08-12 filing 44
Aug 12, 2026 Convertible note “convertible note” language in 8-K (EX-4.1) filed 2026-08-12 filing 39
Aug 12, 2026 PIPE “pipe” language in 8-K (EX-1.1) filed 2026-08-12 filing 33
Aug 12, 2026 Unregistered sale 8-K Item 3.02 filed 2026-08-12 (accepted 16:56 ET) filing 32
Aug 12, 2026 Reverse split “reverse split” language in 8-K (EX-4.1) filed 2026-08-12 filing 32
Aug 12, 2026 Delisting language “delisting notice” language in 8-K (EX-10.1) filed 2026-08-12 filing 32
Aug 12, 2026 New debt obligation 8-K Item 2.03 filed 2026-08-12 (accepted 16:56 ET) filing 27
Aug 6, 2026 Offering (424B) 424B5 prospectus supplement 2026-08-06; 5 prior 424B filings in 12m filing 48
Aug 6, 2026 ATM program “atm” language in 424B5 (424B5) filed 2026-08-06 filing 38
Aug 6, 2026 PIPE “pipe” language in 8-K (EX-10.1) filed 2026-08-06 filing 38
Aug 6, 2026 Registered direct “rdo” language in 424B5 (424B5) filed 2026-08-06 filing 34
Aug 6, 2026 Unregistered sale 8-K Item 3.02 filed 2026-08-06 (accepted 16:13 ET) filing 32
Aug 6, 2026 New debt obligation 8-K Item 2.03 filed 2026-08-06 (accepted 16:13 ET) filing 29
Jul 29, 2026 Material agreement terminated 8-K Item 1.02 filed 2026-07-29 (accepted 17:00 ET) filing 31
Jun 30, 2026 Runway < 6 months ~0.1 months runway: liquidity $205,035 as of 2026-06-30, burn $20,473,276/yr (annualized 180-day YTD operating cash flow [companyfacts]) filing 51
Jun 30, 2026 Negative equity Stockholders' equity $-11,914,635 as of 2026-06-30 filing 31
Jun 30, 2026 Cash < current liabilities Liquidity $205,035 vs current liabilities $20,641,243 filing 21

Other forced raise setups

VIVS VivoSim Labs, INC. · HCWB HCW Biologics Inc. · CYCU Cycurion, Inc. · BIAF bioAffinity Technologies, In · XHLD TEN Holdings, Inc. · VSEE VSEE HEALTH, INC. · screener →

Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans